Literature DB >> 3572304

The fifth component of complement (C5) in the mouse. Analysis of the molecular basis for deficiency.

W H Wheat, R Wetsel, A Falus, B F Tack, R C Strunk.   

Abstract

C5-deficient mice differed from C5-sufficient mice both quantitatively and qualitatively in C5 protein, C5 mRNA, and the C5 gene. C5-deficient protein was present as decreased amounts of an unprocessed, single-chain precursor. C5-deficient mRNA was decreased in amount and present in two forms, the smaller of which was the same as the single form in normal cells. Nuclei from both normal and deficient cells contained the larger form of C5 mRNA, and C5-deficient DNA demonstrated differences from the normal pattern on Southern analysis for two restriction enzymes. These data suggest that the primary transcript of the C5-deficient gene is abnormal, retarding the processing of the C5 mRNA, and that the C5-deficient mRNA codes for an abnormal protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572304      PMCID: PMC2188303          DOI: 10.1084/jem.165.5.1442

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Activity of mouse complement.

Authors:  L T ROSENBERG; D K TACHIBANA
Journal:  J Immunol       Date:  1962-12       Impact factor: 5.422

Review 2.  Compartmental organization of the Golgi stack.

Authors:  W G Dunphy; J E Rothman
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

3.  Glycosylation allows cell-surface transport of an anchored secretory protein.

Authors:  J L Guan; C E Machamer; J K Rose
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

4.  gamma-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes.

Authors:  R C Strunk; F S Cole; D H Perlmutter; H R Colten
Journal:  J Biol Chem       Date:  1985-12-05       Impact factor: 5.157

5.  Human C3 and C5: subunit structure and modifications by trypsin and C42-C423.

Authors:  U R Nilsson; R J Mandle; J A McConnell-Mapes
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

6.  Genetic defect in secretion of complement C5 in mice.

Authors:  Y M Ooi; H R Colten
Journal:  Nature       Date:  1979-11-08       Impact factor: 49.962

7.  Human beta-globin pre-mRNA synthesized in vitro is accurately spliced in Xenopus oocyte nuclei.

Authors:  M R Green; T Maniatis; D A Melton
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

8.  Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide.

Authors:  R C Strunk; A S Whitehead; F S Cole
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

9.  Biosynthesis and post-synthetic modification of a precursor (pro-C5) of the fifth component of mouse complement (C5).

Authors:  Y M Ooi; H R Colten
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

10.  DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT.

Authors:  B CINADER; S DUBISKI; A C WARDLAW
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

  10 in total
  11 in total

Review 1.  Animal models of inherited complement deficiency.

Authors:  S Linton
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

2.  Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.

Authors:  R C Strunk; D M Eidlen; R J Mason
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Complement C5 and early oxygen kinetics during murine sepsis.

Authors:  Gabriel Valencia; J Vidya Sarma; John G Younger
Journal:  Acad Emerg Med       Date:  2005-04       Impact factor: 3.451

4.  Macaque proteome response to highly pathogenic avian influenza and 1918 reassortant influenza virus infections.

Authors:  Joseph N Brown; Robert E Palermo; Carole R Baskin; Marina Gritsenko; Patrick J Sabourin; James P Long; Carol L Sabourin; Helle Bielefeldt-Ohmann; Adolfo García-Sastre; Randy Albrecht; Terrence M Tumpey; Jon M Jacobs; Richard D Smith; Michael G Katze
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

5.  Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3.

Authors:  Scott Shapiro; David O Beenhouwer; Marta Feldmesser; Carlos Taborda; Michael C Carroll; Arturo Casadevall; Matthew D Scharff
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis.

Authors:  Susanna H Weerth; Horea Rus; Moon L Shin; Cedric S Raine
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

7.  Susceptibility to progressive Cryptococcus neoformans pulmonary infection is regulated by loci on mouse chromosomes 1 and 9.

Authors:  Scott F Carroll; Erin I Lafferty; Adam Flaczyk; T Mary Fujiwara; Robert Homer; Kenneth Morgan; J C Loredo-Osti; Salman T Qureshi
Journal:  Infect Immun       Date:  2012-09-17       Impact factor: 3.441

8.  Acute lung injury induced by lipopolysaccharide is independent of complement activation.

Authors:  Daniel Rittirsch; Michael A Flierl; Danielle E Day; Brian A Nadeau; Stephanie R McGuire; Laszlo M Hoesel; Kyros Ipaktchi; Firas S Zetoune; J Vidya Sarma; Lin Leng; Markus S Huber-Lang; Thomas A Neff; Richard Bucala; Peter A Ward
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

9.  Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5).

Authors:  J L Rothstein; T F Lint; H Schreiber
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

10.  A simple PCR-based method for the rapid genotyping of inherited fifth complement component (C5)-deficient mice.

Authors:  Qingkai Wang; Na Wang; Xin Zhang; Weiguo Hu
Journal:  Exp Anim       Date:  2015-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.